{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:58:15Z","timestamp":1793141895675,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific and Technological Research Council of T\u00fcrkiye","award":["124Z037"],"award-info":[{"award-number":["124Z037"]}]},{"name":"Scientific and Technological Research Council of T\u00fcrkiye","award":["124Z037"],"award-info":[{"award-number":["124Z037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11107-9","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:37:50Z","timestamp":1759754270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of the antitumor effects of deferasirox on prostate cancer cells: insights into proliferation, apoptosis, and invasion mechanisms"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8161-2479","authenticated-orcid":false,"given":"Mesut","family":"Aky\u00fcz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8975-1932","authenticated-orcid":false,"given":"Elanur","family":"Aydin Karata\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"11107_CR1","unstructured":"WHO, Globocan (2022) Available from: https:\/\/gco.iarc.fr\/en. Accessed 08 March 2025"},{"issue":"1","key":"11107_CR2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12885-020-07244-y","volume":"20","author":"N Hou\u00e9d\u00e9","year":"2020","unstructured":"Hou\u00e9d\u00e9 N et al (2020) Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study. BMC Cancer 20(1):757","journal-title":"BMC Cancer"},{"issue":"1","key":"11107_CR3","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-019-0862-4","volume":"19","author":"A Ankolekar","year":"2019","unstructured":"Ankolekar A (2019) Development and validation of a patient decision aid for prostate cancer therapy: from paternalistic towards participative shared decision making. BMC Med Inform Decis Mak 19(1):130","journal-title":"BMC Med Inform Decis Mak"},{"key":"11107_CR4","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.16","volume":"4","author":"P Brissot","year":"2018","unstructured":"Brissot P et al (2018) Haemochromatosis. Nat Rev Dis Primers 4:18016","journal-title":"Nat Rev Dis Primers"},{"issue":"21","key":"11107_CR5","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1074\/jbc.M112.350470","volume":"287","author":"Z Chen","year":"2012","unstructured":"Chen Z et al (2012) The iron chelators Dp44mT and DFO inhibit TGF-\u03b2-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem 287(21):17016\u201317028","journal-title":"J Biol Chem"},{"issue":"9","key":"11107_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1280604","volume":"58","author":"YC Chang","year":"2017","unstructured":"Chang YC et al (2017) Deferasirox has strong anti-leukemia activity but May antagonize theanti-leukemia effect of doxorubicin. Leuk Lymphoma 58(9):1\u201312","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"11107_CR7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/bph.12045","volume":"168","author":"SJ Ford","year":"2013","unstructured":"Ford SJ et al (2013) Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo. Br J Pharmacol 168(6):1316\u20131328","journal-title":"Br J Pharmacol"},{"key":"11107_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010198","author":"U Degirmenci","year":"2020","unstructured":"Degirmenci U, Wang M, Hu J (2020) Targeting aberrant RAS\/RAF\/MEK\/ERK signaling for cancer therapy. Cells. https:\/\/doi.org\/10.3390\/cells9010198","journal-title":"Cells"},{"issue":"1","key":"11107_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0090-8258(03)00226-9","volume":"90","author":"T Simonart","year":"2003","unstructured":"Simonart T (2003) Iron withdrawal strategies fail to prevent the growth of SiHa-induced tumors in mice. Gynecol Oncol 90(1):91\u201395","journal-title":"Gynecol Oncol"},{"issue":"6","key":"11107_CR10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1056\/NEJMc1105726","volume":"365","author":"T Yamasaki","year":"2011","unstructured":"Yamasaki T, Terai S, Sakaida I (2011) Deferoxamine for advanced hepatocellular carcinoma. N Engl J Med 365(6):576\u2013578","journal-title":"N Engl J Med"},{"issue":"9","key":"11107_CR11","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","volume":"107","author":"MD Cappellini","year":"2006","unstructured":"Cappellini MD et al (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood 107(9):3455\u20133462","journal-title":"Blood"},{"issue":"8","key":"11107_CR12","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.bbadis.2018.04.011","volume":"1864","author":"KC Park","year":"2018","unstructured":"Park KC et al (2018) Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1. Biochimica et Biophysica Acta (BBA) 1864(8):2644\u20132663","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"11107_CR13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2019.05.020","volume":"157","author":"KC Park","year":"2020","unstructured":"Park KC et al (2020) Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer. Free Radic Biol Med 157:154\u2013175","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"11107_CR14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1074\/mcp.M600249-MCP200","volume":"6","author":"LC Tu","year":"2007","unstructured":"Tu LC (2007) Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics 6(4):575\u2013588","journal-title":"Mol Cell Proteomics"},{"issue":"8","key":"11107_CR15","first-page":"1731","volume":"63","author":"S Bandyopadhyay","year":"2003","unstructured":"Bandyopadhyay S et al (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63(8):1731\u20131736","journal-title":"Cancer Res"},{"issue":"2","key":"11107_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.humpath.2009.07.011","volume":"41","author":"Y Song","year":"2010","unstructured":"Song Y et al (2010) N-myc downstream regulated gene-1\/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Hum Pathol 41(2):214\u2013222","journal-title":"Hum Pathol"},{"issue":"2","key":"11107_CR17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.2012.582","volume":"108","author":"KM Dixon","year":"2013","unstructured":"Dixon KM et al (2013) Dp44mT targets the AKT, TGF-\u03b2 and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells. Br J Cancer 108(2):409\u2013419","journal-title":"Br J Cancer"},{"issue":"6","key":"11107_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/1878-0261.12059","volume":"11","author":"A Sharma","year":"2017","unstructured":"Sharma A et al (2017) The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion. Mol Oncol 11(6):655\u2013669","journal-title":"Mol Oncol"},{"issue":"2","key":"11107_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.yexcr.2004.02.002","volume":"295","author":"TL Cheng","year":"2004","unstructured":"Cheng TL, Symons M, Jou TS (2004) Regulation of anoikis by Cdc42 and Rac1. Exp Cell Res 295(2):497\u2013511","journal-title":"Exp Cell Res"},{"issue":"6","key":"11107_CR20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/sj.bjc.6604152","volume":"98","author":"P McCall","year":"2008","unstructured":"McCall P et al (2008) Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients. Br J Cancer 98(6):1094\u20131101","journal-title":"Br J Cancer"},{"issue":"6","key":"11107_CR21","volume":"297","author":"SC Lim","year":"2021","unstructured":"Lim SC (2021) The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer. J Biol Chem 297(6):101414","journal-title":"J Biol Chem"},{"issue":"12","key":"11107_CR22","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.bbapap.2013.08.009","volume":"1834","author":"N Hosoya","year":"2013","unstructured":"Hosoya N et al (2013) Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma. Biochim Biophys Acta 1834(12):2630\u20132639","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"11107_CR23","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12853","volume":"53","author":"ZY Zhang","year":"2020","unstructured":"Zhang ZY et al (2020) The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma. Cell Prolif 53(7):e12853","journal-title":"Cell Prolif"},{"issue":"2","key":"11107_CR24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/emmm.201100190","volume":"4","author":"W Liu","year":"2012","unstructured":"Liu W (2012) N-myc downstream regulated gene 1 modulates Wnt-\u03b2-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol Med 4(2):93\u2013108","journal-title":"EMBO Mol Med"},{"issue":"16","key":"11107_CR25","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1021\/jm300768u","volume":"55","author":"DB Lovejoy","year":"2012","unstructured":"Lovejoy DB (2012) Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo. J Med Chem 55(16):7230\u20137244","journal-title":"J Med Chem"},{"issue":"1","key":"11107_CR26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1476-5381.2011.01526.x","volume":"165","author":"Y Yu","year":"2012","unstructured":"Yu Y, Suryo Rahmanto Y, Richardson DR (2012) Bp44mt: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy. Br J Pharmacol 165(1):148\u2013166","journal-title":"Br J Pharmacol"},{"key":"11107_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2017.04.031","volume":"401","author":"Y Wang","year":"2017","unstructured":"Wang Y et al (2017) N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc. Cancer Lett 401:53\u201362","journal-title":"Cancer Lett"},{"issue":"2","key":"11107_CR28","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002279R","volume":"35","author":"B Geleta","year":"2021","unstructured":"Geleta B et al (2021) Breaking the cycle: targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma. FASEB J 35(2):e21347","journal-title":"FASEB J"},{"key":"11107_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235739","author":"V Joshi","year":"2022","unstructured":"Joshi V, Lakhani SR, McCart Reed AE (2022) NDRG1 in cancer: a suppressor, promoter, or both? Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14235739","journal-title":"Cancers (Basel)"},{"issue":"1","key":"11107_CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2022.05.006","volume":"166","author":"N Zhou","year":"2022","unstructured":"Zhou N (2022) Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo. Gynecol Oncol 166(1):126\u2013137","journal-title":"Gynecol Oncol"},{"issue":"1","key":"11107_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1248\/bpb.b22-00440","volume":"46","author":"F Jiang","year":"2023","unstructured":"Jiang F et al (2023) Pachymic acid inhibits growth and metastatic potential in liver cancer HepG2 and Huh7 cells. Biol Pharm Bull 46(1):35\u201341","journal-title":"Biol Pharm Bull"},{"issue":"33","key":"11107_CR32","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1038\/sj.onc.1207734","volume":"23","author":"S Bandyopadhyay","year":"2004","unstructured":"Bandyopadhyay S et al (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23(33):5675\u20135681","journal-title":"Oncogene"},{"issue":"3","key":"11107_CR33","first-page":"749","volume":"60","author":"RJ Guan","year":"2000","unstructured":"Guan RJ et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60(3):749\u2013755","journal-title":"Cancer Res"},{"issue":"4","key":"11107_CR34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"36","key":"11107_CR35","doi-asserted-by":"crossref","first-page":"60243","DOI":"10.18632\/oncotarget.19521","volume":"8","author":"OF Karatas","year":"2017","unstructured":"Karatas OF et al (2017) MiR-33a is a tumor suppressor MicroRNA that is decreased in prostate cancer. Oncotarget 8(36):60243\u201360256","journal-title":"Oncotarget"},{"issue":"5","key":"11107_CR36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13(5):342\u2013355","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"11107_CR37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1753-4887.2001.tb07002.x","volume":"59","author":"RL Nelson","year":"2001","unstructured":"Nelson RL (2001) Iron and colorectal cancer risk: human studies. Nutr Rev 59(5):140\u2013148","journal-title":"Nutr Rev"},{"key":"11107_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020273","author":"M Jung","year":"2019","unstructured":"Jung M (2019) Iron as a central player and promising target in cancer progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20020273","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11107_CR39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/16078454.2018.1557860","volume":"24","author":"BS Ko","year":"2019","unstructured":"Ko BS et al (2019) Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan. Hematology 24(1):247\u2013254","journal-title":"Hematology"},{"issue":"4","key":"11107_CR40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3892\/ijo.2016.3640","volume":"49","author":"S Nishitani","year":"2016","unstructured":"Nishitani S (2016) Iron depletion-induced downregulation of N-cadherin expression inhibits invasive malignant phenotypes in human esophageal cancer. Int J Oncol 49(4):1351\u20131359","journal-title":"Int J Oncol"},{"issue":"5","key":"11107_CR41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1124\/mol.115.103044","volume":"89","author":"X Wangpu","year":"2016","unstructured":"Wangpu X et al (2016) Targeting the metastasis suppressor, N-Myc downstream regulated gene-1, with novel di-2-pyridylketone thiosemicarbazones: suppression of tumor cell migration and cell-collagen adhesion by inhibiting focal adhesion kinase\/Paxillin signaling. Mol Pharmacol 89(5):521\u2013540","journal-title":"Mol Pharmacol"},{"issue":"1","key":"11107_CR42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-019-0348-0","volume":"17","author":"P Luo","year":"2019","unstructured":"Luo P et al (2019) Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect. Cell Commun Signal 17(1):36","journal-title":"Cell Commun Signal"},{"issue":"30","key":"11107_CR43","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/onc.2017.74","volume":"36","author":"L Mi","year":"2017","unstructured":"Mi L et al (2017) The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells. Oncogene 36(30):4323\u20134335","journal-title":"Oncogene"},{"issue":"1","key":"11107_CR44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1124\/mol.112.081893","volume":"83","author":"GY Lui","year":"2013","unstructured":"Lui GY (2013) The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action. Mol Pharmacol 83(1):179\u2013190","journal-title":"Mol Pharmacol"},{"key":"11107_CR45","doi-asserted-by":"crossref","unstructured":"Chalermpanapun P, Theerasilp M, Nasongkla N (2016) Deferasirox-loaded polymeric micelles as nanoformulated iron chelating chemotherapy of prostate cancer. In BMEiCON 2015\u20138th Biomedical Engineering International Conference Article 7399522. Institute of Electrical and Electronics Engineers Inc","DOI":"10.1109\/BMEiCON.2015.7399522"},{"key":"11107_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.3712","author":"RV Sim\u00f5es","year":"2017","unstructured":"Sim\u00f5es RV et al (2017) Inhibition of prostate cancer proliferation by deferiprone. NMR Biomed. https:\/\/doi.org\/10.1002\/nbm.3712","journal-title":"NMR Biomed"},{"issue":"4","key":"11107_CR47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/mol.111.073627","volume":"80","author":"Z Kovacevic","year":"2011","unstructured":"Kovacevic Z et al (2011) Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer. Mol Pharmacol 80(4):598\u2013609","journal-title":"Mol Pharmacol"},{"issue":"16","key":"11107_CR48","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.4161\/cc.6.16.4603","volume":"6","author":"Y Yu","year":"2007","unstructured":"Yu Y, Kovacevic Z, Richardson DR (2007) Tuning cell cycle regulation with an iron key. Cell Cycle 6(16):1982\u20131994","journal-title":"Cell Cycle"},{"key":"11107_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101414","author":"SC Lim","year":"2021","unstructured":"Lim SC (2021) The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2021.101414","journal-title":"J Biol Chem"},{"issue":"13","key":"11107_CR50","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.7150\/ijbs.63300","volume":"17","author":"YJ Quan","year":"2021","unstructured":"Quan YJ et al (2021) The role of N-cadherin\/c-Jun\/NDRG1 axis in the progression of prostate cancer. Int J Biol Sci 17(13):3288\u20133304","journal-title":"Int J Biol Sci"},{"issue":"1","key":"11107_CR51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/gyno.2001.6570","volume":"85","author":"T Simonart","year":"2002","unstructured":"Simonart T (2002) Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. Gynecol Oncol 85(1):95\u2013102","journal-title":"Gynecol Oncol"},{"issue":"24","key":"11107_CR52","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.7150\/jca.25811","volume":"9","author":"JB Chen","year":"2018","unstructured":"Chen JB et al (2018) Glucocorticoid-inducible kinase 2 promotes bladder cancer cell proliferation, migration and invasion by enhancing \u03b2-catenin\/c-myc signaling pathway. J Cancer 9(24):4774\u20134782","journal-title":"J Cancer"},{"issue":"13","key":"11107_CR53","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/cncr.30667","volume":"123","author":"W Small","year":"2017","unstructured":"Small W et al (2017) Cervical cancer: a global health crisis. Cancer 123(13):2404\u20132412","journal-title":"Cancer"},{"issue":"6","key":"11107_CR54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/09553002.2020.1694188","volume":"96","author":"X Tian","year":"2020","unstructured":"Tian X et al (2020) Single high dose irradiation induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cells through the Ras\/Raf\/MEK\/ERK pathways. Int J Radiat Biol 96(6):740\u2013747","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"11107_CR55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13046-019-1397-3","volume":"38","author":"F Wang","year":"2019","unstructured":"Wang F et al (2019) Iron and leukemia: new insights for future treatments. J Exp Clin Cancer Res 38(1):406","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11107-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:04Z","timestamp":1766898184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11107-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11107"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11107-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study involved only in vitro experiments using prostate cell lines. Therefore, ethical approval and informed consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"988"}}